Dominant variants in TTN may underlie a proportion of skeletal myopathy disorders which currently remain genetically uncharacterized and should be considered in the differential diagnosis of patients with skeletal muscle weakness and cardiomyopathy. The gene discussed is TTN; the disease is cardiomyopathy.